Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
about
XELOX (capecitabine plus oxaliplatin) as first-line treatment for elderly patients over 70 years of age with advanced colorectal cancerA phase II study of oxaliplatin, 5-fluorouracil, leucovorin, and high-dose capecitabine in patients with metastatic colorectal cancer.Emerging roles of frailty and inflammaging in risk assessment of age-related chronic diseases in older adults: the intersection between aging biology and personalized medicine.Gemcitabine in elderly patients with advanced pancreatic cancerFirst line palliative chemotherapy in elderly patients with advanced soft tissue sarcoma.A review of oxaliplatin and its clinical use in colorectal cancer.Treatment of elderly cancer patients with chemotherapy.Phase II study of capecitabine and mitomycin C as first-line treatment in patients with advanced colorectal cancerElderly patients with fluoropyrimidine and thymidylate synthase inhibitor-resistant advanced colorectal cancer derive similar benefit without excessive toxicity when treated with irinotecan monotherapy.Oxaliplatin in the treatment of colorectal cancer.Folfirinox in elderly patients with pancreatic or colorectal cancer-tolerance and efficacy.XELOX in colorectal cancer: a convenient option for the future?Targeted agents: review of toxicity in the elderly metastatic colorectal cancer patients.Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013.Randomized phase III trial in elderly patients comparing LV5FU2 with or without irinotecan for first-line treatment of metastatic colorectal cancer (FFCD 2001-02).Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly.FOLFOX in patients aged between 76 and 80 years with metastatic colorectal cancer: an exploratory cohort of the OPTIMOX1 study.
P2860
Q33370632-761D3EA5-3FCE-4B82-A00C-678E0978D902Q34682635-BEE2A282-C062-47EB-BCE9-F22B0D6B2985Q35097723-AAAA7579-22AD-44C2-B6DA-74C480CC1C6DQ35185110-8E2A2B30-7B46-4BEC-8583-2A5E7DB8FA7DQ35544697-2CE3B776-6B31-45B5-90DB-3D81C3886040Q35906940-412F619A-BFC0-4380-8452-9B79F861B8BDQ36276360-27523A50-09D8-4FD4-B641-CC612FD58D3EQ36695635-ECB668D3-15F1-412F-9565-A07D11AA186EQ36695795-EDA3715A-740A-4C91-8A48-69C791EF0A12Q36788436-1167E7B2-814B-4AE6-8F23-543D1C3F7B72Q37411495-F76CE5A9-F759-4466-9006-6DAB60ED7751Q37839084-788D5C4F-D0DE-44C9-B719-14DB75D833A3Q37954162-8BDEF222-08A4-49FA-ABFB-45BE15A3CDCEQ38228522-FA958B3C-6B58-45E6-BBBF-8B8EBFE935CEQ40407871-D6236D21-8FCF-4365-BF58-92888DB3419CQ43248670-68CB1A6E-C8C4-454F-9681-381300E22EB3Q46929599-6BEFF42E-87BC-489C-AD33-E2249E3D6CD0
P2860
Oxaliplatin- or irinotecan-based chemotherapy for metastatic colorectal cancer in the elderly
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Oxaliplatin- or irinotecan-bas ...... lorectal cancer in the elderly
@ast
Oxaliplatin- or irinotecan-bas ...... lorectal cancer in the elderly
@en
type
label
Oxaliplatin- or irinotecan-bas ...... lorectal cancer in the elderly
@ast
Oxaliplatin- or irinotecan-bas ...... lorectal cancer in the elderly
@en
prefLabel
Oxaliplatin- or irinotecan-bas ...... lorectal cancer in the elderly
@ast
Oxaliplatin- or irinotecan-bas ...... lorectal cancer in the elderly
@en
P2093
P2860
P356
P1476
Oxaliplatin- or irinotecan-bas ...... lorectal cancer in the elderly
@en
P2093
I Etienney
S Dominguez
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601310
P407
P50
P577
2003-10-01T00:00:00Z
P5875
P6179
1038366467